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Background Takayasu arteritis (TAK) is a rare chronic inflammatory vasculitis predominantly affecting the aorta and its main
branches. Takayasu arteritis has been shown to increase cardiovascular risk. Supervised exercise training (SET) is a
well-recognized and effective therapeutic tool improving walking performances in patients with chronic athero-
sclerotic disease; however, the effects of SET, and the underlying mechanisms, remain poorly documented in TAK
patients.
...................................................................................................................................................................................................
Case summary We reviewed the literature and investigated the effects of a 12-week SET programme on walking performan-
ces, physical function, and calf muscle oxygen saturation (StO2; assessed by near-infrared spectroscopy) dur-
ing exercise in a 28-year-old man with TAK and symptoms of arterial lower limb claudication. The literature
review evidences only two recent publications suggesting that exercise training is effective and well-tolerated
in patients with arteritis. The treadmill pain-free (þ22%) and maximal (þ273%) walking distance, 6-min walk-
ing distance (þ66%), and physical function of lower extremities (þ20%) following SET were significantly
improved in our patient. Moreover, we observed a greater muscle oxygen desaturation (increased oxygen ex-
traction) during exercise.
...................................................................................................................................................................................................
Discussion Following SET, the increased oxygen extraction may be related to improved microvascular milieu leading to a bet-
ter match between muscle oxygen supply and demand during exercise. These new results may contribute to mech-
anistic insights in peripheral adaptations following exercise training in TAK patients and may help to explain, at least
partly, the increased walking performances. Although more studies are needed to better explore the impact of ex-
ercise training, these results suggest that exercise should be recommended in TAK patients.
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..Introduction
Takayasu arteritis (TAK) is a rare chronic inflammatory vasculitis that
predominantly leads to stenosis, occlusion, and/or aneurysm of the
aorta and its main branches.1 Takayasu arteritis mainly occurs in
young females.1 Clinical manifestations are diminished/absent periph-
eral pulses, asymmetric blood pressure in either upper or lower
limbs, peripheral ischaemia, and arterial claudication.1 Daily life activ-
ities may be compromised, with consequent reduced physical func-
tion, and decreased quality of life.1–3 Patients with TAK are at higher
risk of cardiovascular events.4 It has recently been shown that exer-
cise training is effective and well-tolerated in female patients with
TAK3 and that may increase walking performance and quality of life in
a male patient with arteritis and symptoms of claudication of lower
limbs.5 However, the underlying mechanisms remain poorly investi-
gated. In patients with lower extremity artery disease (LEAD), pre-
senting similar symptoms of claudication than TAK patients,
adaptations to exercise training mainly reside at the skeletal muscle
level.6 Therefore, one may hypothesize that similar adaptations may
also occur in symptomatic TAK patients.
Near-infrared spectroscopy (NIRS) is a non-invasive system meas-
uring muscle oxygen saturation [StO2 (%)], indicative of tissue oxy-
genation.7 Near-infrared spectroscopy-assessed StO2 may therefore
provide information on the balance between oxygen consumption
and delivery within the skeletal muscle at rest and during exercise,7
contributing to new mechanistic insights following exercise training in
TAK patients.
We presented here a review of the literature in the topic of exer-
cise training and arteritis and the first case of a 28-year-old man with
TAK and symptoms of arterial lower limb claudication being eval-
uated with NIRS during exercise before and after a 12-week super-
vised exercise training (SET). In addition, physical function of lower
extremities was also assessed.
Learning points
• Exercise training increases walking performance and physical function and should be recommended in TAK patients.
• One of the possible underlying mechanisms may be an improved microvascular milieu leading to a better match between muscle oxygen
supply and demand during exercise.
....................................................................................................................................................................................................................
Time Events
Between 18 and 16 months
prior to
supervised exercise training
(SET)
• Diagnosis of TAK
• CRP = 292 mg L-1
• Lower limb claudication: 50 m
• Treatment: i.v. corticosteroid therapy, Prednisone 45 mg day-1 (1 mg kg day-1) and Methotrexate 10 mg week-1
Between 16 and 12 months
prior to SET
• Lower limb claudication: 200 m
• CRP = 1 mg L-1
• Treatment: Methotrexate 10 mg week-1; Prednisone decrease until 17.5 mg day-1
Between 12 and 11 months
prior to SET
• Abdominal pain
• CRP = 91 mg L-1
• Treatment: Prednisone 40 mg day-1 and Tocilizumab 8 mg kg month-1, Methotrexate was stopped
Between 11 and 7 months prior
to SET
• Lower limb claudication: 200 m
• No significant sign of inflammation
• CRP = 1 mg L-1
• Treatment: Prednisone decrease until 10 mg day-1, Tocilizumab 8 mg kg month-1
Between 4 months to the
beginning of SET
• Lower limb claudication: 200 m
• No significant sign of inflammation
• CRP = 1 mg L-1
• Treatment: Prednisone decreases until 5 mg day-1, Tocilizumab 8 mg kg month-1
• SET was initiated
Following SET • Significant improvement in walking performances and physical function
• No significant sign of inflammation
• CRP <1 mg L-1
Timeline
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Patient information
A 28-year-old man (body mass index 17.8 kg/m2) with TAK, renal ar-
tery stenosis with hypertension and symptoms of arterial lower limbs
claudication was investigated (Figure 1). The patient had no active
comorbidities and was non-smoker. Eighteen months prior to SET,
the patient was hospitalized for abdominal and lower extremity pain
(claudication: 50 m), myalgia, and fever. Peripheral pulses were pre-
sent only in femoral arteries; ankle-brachial index was 0.80 (right leg)
and 0.57 (left leg). Vascular Duplex examination revealed thickness of
the arterial wall and stenosis/occlusion of digestive, renal, and ilio-
femoral arterial axes. Systemic inflammation (CRP) was 292 mg L-1.
Treatment included intravenous corticosteroid therapy, followed by
Prednisone 1 mg kg-1 day-1 and Methotrexate 10 mg week-1. After
6 months, by reason of an adverse evolution, with abdominal pain,
persistence of significant lower limb claudication and biologic inflam-
mation, a treatment modification was proposed. In the following
months, inflammation was reduced and stabilized. The patient was
then proposed to participate to a SET programme.
Physical examination
Physical examination before beginning of SET revealed high blood
pressure values (systolic blood pressure 151 mmHg; diastolic blood
pressure 101 mmHg) with a normal resting heart rate. Peripheral
pulses were present at the femoral artery level bilaterally
and not perceived distally. Respiratory examination revealed no
abnormalities.
Functional assessments
Functional assessments were performed before and following SET.
Walking performances
Constant-load treadmill test
This test was performed at 3.2 km h-1 with a 12% slope to determine
pain-free walking distance (PFWD) and maximal walking distance
(MWD). Calf StO2 was monitored both at rest and during exercise
with continuous wave NIRS (PortaMon, Artinis, The Netherlands).
Near-infrared spectroscopy probe was placed over the lateral
gastrocnemius muscle corresponding to the maximum girth of the
calf of the most affected leg. Near-infrared spectroscopy probe was
positioned with 3.5 cm inter-optode spacing. The signal was recorded
at 10 Hz and a differential pathlength factor of 6.0 was used.
Six-minute walking test
This test was performed in an indoor 50 m-corridor to determine
the 6 min-walking distance (6MWD). Patient was asked to walk as
much as possible within 6 min. At the end of the test, patient eval-
uated leg pain using a visual analogue scale (‘no pain’: 0 and ‘worst im-
aginable pain’: 10).
Physical function
Lower limb function was assessed by means of the Short Physical
Performance Battery test and the stair climbing test.8,9
Figure 1 Computed tomography angiography (maximum inten-
sity projection 3D reconstruction) showing multiple stenoses/
occlusions of iliac and femoral arteries.
.................................................................................................
Table 1 Walking performances and physical function
of lower extremities before and after the supervised
exercise training programme
Variables Before After Change (%)
Walking performance
PFWD (m) 90.0 110.0 þ22
MWD (m) 150.0 560.0 þ273
6MWD (m) 352.0 585.0 þ66
Resting time during 6MWT (s) 110 0
6MWTvas 6.2 2.0 -68
SPPB
Stand test summed (s) 30.0 30.0 0
4-m velocity test (m s-1) 1.1 1.6 þ43
5 chair stand test (s) 14.0 5.9 -58
SPPB total score 10.0 12.0 þ20
SCT (s) 5.5 3.1 -43
MWD, maximal walking distance; 6MWD, six-minute walking distance; 6MWTvas,
visual analogical scale at the end of the 6-min walking test; PFWD, pain-free walk-
ing distance; SCT, stair climbing test; SPPB, short physical performance battery...
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Supervised exercise training
Supervised exercise training consisted of 36 sessions, three times a
week, over a 12 week period. Each training session started with a 5–
10 min warm-up and ended with a 5-min stretching cool-down
period. One session weekly was mainly focused on strengthening of
lower limbs and include different type of walking (heel and toe walk-
ing, skipping walking, side-to-side walking, power-jogger walking) and
resistance exercises focused on the main muscle groups of the lower
limbs performed with an elastic band. During the two other weekly
sessions, outdoor Nordic walking was performed. Training session
duration was progressively increased (from 30 to 55 min) according
to patient’s tolerance. The intensity was mainly set at 12–14 on the
15-grade Borg scale (moderate intensity).10
Follow-up and outcomes
The patient completed the training programme. Walking performan-
ces (PFWD: þ22%; MWD: þ273%; 6MWD: þ66%) and physical
function of lower extremities (þ20%) significantly increased (Table 1)
and muscle oxygen desaturation during exercise was greater after
SET (Figure 2A and B).
Review of the literature
We performed a review of the literature on the topic of exercise
training and arteritis in Pubmed and Embase (Supplementary material
online). After screening procedure, we found two publications (one
article and one case report; Table 2).
A
B
Figure 2 Calf muscle oxygen saturation (StO2) (A) and delta StO2 (DStO2) (B) at rest (StO2R), during the first 2 minutes of effort and at the pain-
free walking distance (PFWD) and maximal walking distance (MWD). StO2R was recorded after 3 min of standing before exercise. Each time point
was calculated as the average StO2 during the last 15 s andDStO2 was calculated as the StO2 at each time point minus the baseline StO2.
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.Discussion
Exercise training is poorly investigated in patients with arteritis. Present
results show that walking performances and physical function increase
after SET in a TAK patient. In addition, we observed a greater muscle
oxygen desaturation during exercise in the post-training condition.
The improvements of walking performance are in line with previ-
ous observations reported in LEAD patients.11 One of the possible
underlying mechanism associated with walking improvement may
reside at the skeletal muscle level. It has recently been shown that ex-
ercise training may increase microvascular skeletal muscle blood flow
during exercise in LEAD patients.12 This is probably related to
improvements in endothelium-dependent vasodilation and increased
capillary density.6,12,13 These adaptive responses may lead to
increased oxygen extraction from the skeletal muscle, and therefore
improve muscle oxidative metabolism during exercise.6,12–15
Therefore, the greater muscle oxygen desaturation (i.e. increased
oxygen extraction) during exercise observed after SET in our patient,
may be related to an improved microvascular milieu leading to a bet-
ter match between muscle oxygen supply and demand during exer-
cise. These results may help to explain, at least partly, the observed
increased walking performances and exercise tolerance and contri-
buting to new mechanistic insights following exercise training in TAK
patients. In addition, physical function of lower extremities also
increased after SET, confirming recent results in TAK patients.3
Conclusion
Beneficial effect of SET in non-atherosclerotic patients will need
to be confirmed in a properly conducted randomized control
trial. However, based on our findings and on previous results,
SET seems to be beneficial and may be recommended in TAK
patients.
Supplementary material
Supplementary material is available at European Heart Journal - Case
Reports online.
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